Spx, a member of the ArsC protein family, is a regulatory factor that interacts with RNA polymerase (RNAP). It is highly conserved in Gram-positive bacteria and controls transcription on a genome-wide scale in response to oxidative stress. The structural requirements for RNAP interaction and promoter DNA recognition by Spx were examined through mutational analysis. Residues near the CxxC redox disulfide center of Spx functioned in RNAP ␣ subunit interaction and in promoter DNA binding. R60E and C10A mutants were shown previously to confer defects in transcriptional activation, but both were able to interact with RNAP. R92, which is conserved in ArsC-family proteins, is likely involved in redox control of Spx, as the C10A mutation, which blocks disulfide formation, was epistatic to the R92A mutation. The R91A mutation reduced transcriptional activation and repression, suggesting a defect in RNAP interaction, which was confirmed by interaction assays using an epitope-tagged mutant protein. Protein-DNA cross-linking detected contact between RNAP-bound Spx and the AGCA element at ؊44 that is conserved in Spx-controlled genes. This interaction caused repositioning of the RNAP A subunit from a ؊35-like element upstream of the trxB (thioredoxin reductase) promoter to positions ؊36 and ؊11 of the core promoter. The study shows that RNAP-bound Spx contacts a conserved upstream promoter sequence element when bound to RNAP.
B
acterial responses to environmental and metabolic changes often involve gene regulation at the level of transcription initiation. The essential enzyme catalyzing this first step of gene expression, RNA polymerase (RNAP), is targeted by a variety of regulatory factors that direct RNAP activity to specific transcription units (1) . The core RNAP, bearing the catalytic component, is composed of large subunits, ␤ and ␤=, the ␣ subunit dimer, and the subunit. Interaction of core RNAP with the subunit gives rise to the holoenzyme endowed with gene promoter specificity (2, 3) . Regulatory factors that are controlled by signal sensing/ transducing systems that mediate stress responses can target one or more of the RNAP subunits to modulate activity and promoter specificity. Some regulatory factors exert positive control by engaging promoter DNA and recruiting RNAP through direct protein-RNAP subunit interaction (1) . There is a growing list of regulatory proteins that prerecruit or appropriate RNAP by first contacting holoenzyme before mediating DNA target recognition (4) . One of them, AsiA of phage T4, serves to mediate contact between RNAP subunit and a phage-encoded DNA-bound factor, MotA, which triggers prereplicative phage gene transcription (5) . The DksA/Gre family proteins target the RNAP active site to affect transcription initiation and elongation at specific promoters (6) . SoxS and related proteins engage in prerecruitment by interacting with holoenzyme before contacting specific cis-acting promoter elements (7) . Other factors, such as Crl and 6S RNA, stabilize or inhibit specific holoenzyme forms bearing distinct subunits (8, 9) .
In low-GC Gram-positive bacteria, the Spx family of proteins controls transcription initiation in response to thiol-reactive agents (10) . A variety of genes/operons are activated by Spx, including those whose products function in thiol homeostasis, in low-molecular-weight redox buffer biosynthesis, and in cysteine biosynthesis/uptake (11) (12) (13) (14) . Spx is often encoded by paralogous genes within certain bacterial species (15) , and in some cases the genes are essential and/or required for bacterial virulence in pathogenic species (16) (17) (18) . Spx is a monomer in solution, and a single monomer engages RNAP by contacting the ␣ dimer (19) . Spx has higher affinity for holoenzyme bearing the A subunit than for core RNAP, although there is little evidence that Spx directly contacts sigma (19, 20) . Free Spx protein of B. subtilis does not bind to DNA, although when it interacts with holoenzyme it directs RNAP to promoter regions that bear a conserved upstream sequence motif, which is usually AGCA, centered approximately at position Ϫ44 with respect to the transcription start site (21, 22) . This sequence assignment was supported by recent chromatin immunoprecipitation (ChIP)-chip analysis, which also showed that Spx/RNAP complex targeted 144 operons in the B. subtilis genome (14) .
The expression of spx in B. subtilis is under multilevel control. Transcription is catalyzed by four different RNAP holoenzyme forms and is under negative control by PerR and YodB, which are sensitive to peroxide-and thiol-reactive agents, respectively (23) (24) (25) (26) (27) . The activity of Spx is controlled by a redox switch involving an N-terminal CXXC thiol/disulfide center. Spx mediates RNAPpromoter interaction when in the oxidized, disulfide form, as Spx/ RNAP contact with promoter DNA is abolished in the presence of reductant (21) . Lastly, Spx is under proteolytic control mediated by the ATP-dependent protease, ClpXP, and a substrate recogni-tion factor, YjbH (28, 29) . Proteolytic control is responsive to oxidative stress, as Spx protein accumulates to elevated concentrations in cells that encounter toxic, thiol-reactive oxidants (30, 31) .
Many questions remain to be answered with respect to the mechanism of Spx-activated transcription. It is not known how Spx maintains higher affinity for holoenzyme than for RNAP lacking A , or if Spx contacts promoter DNA. It is not known why the oxidized form of Spx promotes RNAP-promoter DNA contact, and it is not clear why only one Spx monomer contacts the ␣ dimer. Previous structural studies showed that Spx contacts the C-terminal domain of the ␣ subunit (␣CTD), and that an ␣ helix in Spx, ␣4 (Fig. 1) , becomes unfolded upon reduction of the Spx disulfide center (32) . An amino acid substitution, R60E, in this region of the protein affects Spx-dependent activation and prevents a complex of Spx and ␣CTD from binding to promoter DNA.
The structural analysis of the Spx protein uncovered two domains: a redox domain consisting of the N-and C-terminal regions and containing the redox disulfide center (C10TSC13), and the central domain that contains the ␣CTD binding surface (defined by the spx codon substitution G52R [20, 33] ) and the ␣4 helix (residue R60 to V69 [32] ). The two domains are separated by a linker of two coils bearing residues which, in ArsC, function in catalysis (34) . This report presents a study in which residue substitutions in the linker and ␣4 helix of Spx were generated that affect RNAP and ␣ subunit interaction. Together, the data suggest the presence of an additional site on Spx required for ␣ subunit contact. Data are also presented that demonstrate Spx direct contact with the conserved upstream AGCA element, and that defects in DNA contact are conferred by Spx residue substitutions that affect Spx-activated transcription. DNA-protein cross-linking data show that Spx interaction with RNAP and the AGCA upstream element results in a repositioning of the A subunit, resulting in its contact with the core promoter.
MATERIALS AND METHODS
Bacterial strains and culture conditions. All bacterial strains and plasmids are listed in Table S1 in the supplemental material. The B. subtilis strains used in this study are derivatives of JH642 and were grown at 37°C in 2ϫ yeast extract-tryptone (2ϫ YT) or Difco sporulation medium (DSM) (35) . Escherichia coli DH5␣ was used for plasmid construction. Strain ER2566 (New England BioLabs) was used for protein production by an intein-chitin system. Plasmid-bearing E. coli strains were grown at 37°C in 2ϫ YT liquid or on lysogeny broth (LB) solid medium containing 1.2% agar (Difco). For overproduction and purification of Spx proteins in E. coli strain ER2566, cells were grown at 37°C in LB liquid medium. Antibiotic concentrations used were as previously reported (35, 36) . For trpC2 pheA1 phenotype confirmation, JH642 derivatives were streaked on a TSS minimal medium agar plate with or without tryptophan and phenylalanine supplements.
Construction of Spx amino acid substitution mutants. The effect of Spx amino acid substitution was examined using spx constructs bearing amino acid codon substitutions (AN to DD) at the carboxyl-terminal coding end, which gives rise to the spxDD allele. The product of spxDD is resistant to ClpXP proteolysis (13) . The previously constructed plasmid pSN56 (13) is a pDR111 derivative that was used to express spxDD and mutant versions. pDR111 is an amyE integration vector, and the cloned spx alleles were expressed from the isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible P spankhy promoter of the plasmid (37) . The codon substitutions were generated by two-step PCR mutagenesis with pairs of complementary mutagenic oligonucleotides (listed in Table S2 in the supplemental material) as described previously (32) . Plasmids were used to transform ORB4566 (spx::neo thrC::trxB-lacZ) for assays of trxB-directed ␤-galactosidase activity.
To construct the expression plasmids containing Spx mutant proteins used for in vitro transcription and in vitro affinity interaction assay, twostep PCR-based mutagenesis was performed using plasmids pMMN470 (38) and pAL46 (19) as the templates to generate the desired amino acid substitution. The pMMN470 and pAL46 plasmids are pTYB4 derivatives carrying wild-type spx and spx⌬CHA, respectively. DNA fragments were digested with NcoI and SmaI and then inserted into pTYB4, which is an E. coli expression vector used in the Impact kit (New England BioLabs). The recombinant plasmids were introduced by transformation into E. coli strain ER2566 for protein expression.
␤-Galactosidase assays. Strains were grown in liquid DS medium. Strains bearing a trxB-lacZ fusion (see Table S1 in the supplemental material) were grown at 37°C overnight on DS medium agar plates supplemented with the appropriate antibiotics. The overnight cultures were used to inoculate the same liquid medium at a starting optical density at 600 nm (OD 600 ) of 0.02. When the OD 600 of the cultures reached 0.4, the cultures were divided into two flasks and 1 mM IPTG was added to one of the flasks. Samples were collected every 30 min, and ␤-galactosidase activity was assayed as previously described (39) ; data are presented as Miller units (40) .
Western blot analysis. Samples were collected at the same time when growing the strains for ␤-galactosidase assays, and the cells were lysed in lysis buffer (30 mM Tris-HCl, pH 8.0, 1 mM EDTA) by the bead-beating method. The cell pellet was suspended in lysis buffer, mixed with 0.1-mm disruption glass beads (RPI Corp.) by vortexing for 5 min, and transferred onto ice for 5 min. Two more vortexing cycles were repeated, followed by centrifugation. The supernatant of each sample was collected, and the protein concentration was measured with Coomassie protein assay reagent (Pierce). Ten g of the total protein for each sample was loaded onto an SDS-PAGE gel. The Western blot was undertaken as previously described using an anti-Spx antibody (35) .
Protein purification. His-tagged A -depleted RNAP (SAd-RNAP) was purified from the A subunit mutant B. subtilis strain ORB5853 (rpoC-His 10 , sigA-L366A), in which the Leu366 substitution in A weakens the interaction with the RNAP core enzyme (41). As described previously (19) , B. subtilis cells were grown in 2ϫ YT liquid containing chloramphenicol and neomycin at 37°C until the OD 600 of the culture reached 0.8 to 0.9. The cells were harvested and lysed by passage through a French press. The protein was purified stepwise with three columns, a HisPur nickel-nitrilotriacetic acid (Ni-NTA; Thermo Scientific) affinity column, a heparin column, and a Bio-Rad High Q column, as previously described (22, 32) , and then stored at Ϫ20°C in buffer containing 10 mM Tris-HCl, pH 7.8, 100 mM KCl, 5 mM MgCl 2 , 0.1 mM EDTA, and 50% glycerol.
The genes specifying A subunit and Spx variants were cloned in plasmid pTYB4 (terminus Impact CN system; New England BioLabs). The products of the recombinant plasmids bear self-cleavable intein-and chitin-binding domains positioned at the C termini.
A was overproduced from plasmid pSN64 (42) in E. coli ER2566 and purified by using chitin resins (New England BioLabs) followed by a Bio-Rad High Q column. Purified A was dialyzed and stored at Ϫ80°C in buffer containing 25 mM Tris-HCl, pH 8.0, 100 mM KCl, 0.1 mM EDTA, 1 mM MgCl 2 , and 10% glycerol. Spx variants were expressed from pTYB4 derivatives listed in Table S1 in the supplemental material. As previously described, Spx proteins were purified by using a chitin column followed by a Bio-Rad High S column (35) . Spx proteins were stored at Ϫ80°C in buffer containing 10 mM Tris-HCl, pH 8.0, 100 mM KCl, 5% glycerol.
In vitro transcription. The trxB promoter DNA (Ϫ200 to ϩ30) fragment was generated by PCR amplification with oligonucleotides oDW7 and oDY8 and inserted into the TOPO vector with a Zero Blunt TOPO PCR cloning kit (Invitrogen, Life Technologies) to generate pDW4. The trxB promoter DNA fragment was further cleaved out of pDW4 with restriction endonucleases EcoRI and HindIII and inserted into plasmid pRLG770 (43) to generate plasmid pDW10. pRLG770 was designed as a supercoiled DNA template for in vitro transcription, and it contains a cloning site for inserting promoter DNA fragments of interest, two terminators, and an internal control RNA-1 transcription unit (43) .
For the transcription reaction, a 3-fold molar excess of A subunit was preincubated with SAd-RNAP at 37°C in buffer containing 10 mM TrisHCl, pH 8.0, 10 mM MgCl 2 , 30 mM KCl, and 50% glycerol for 1 h to assemble the RNAP holoenzyme (holo-RNAP). In each reaction, 100 ng of pDW10 template was incubated with 10 nM Spx, 10 nM holo-RNAP, and 5 Ci of [␣-
32 P]UTP (3,000 Ci/mmol) in 50 l of 10 mM Tris-HCl, pH 8.0, 30 mM KCl, 0.5 mM MgCl 2 , and 1 mg/ml bovine serum albumin (BSA) at 37°C. After 10 min, the nucleotide mixture (0.2 mM rATP/rGTP/ rCTP and 10 nM UTP, final concentration) was then added to initiate the reaction. Ten l of sample was taken and mixed with an equal volume of sequencing stop solution (95% formamide, 25 mM EDTA, 0.05% bromophenol blue) to stop the reaction after 2, 5, 10, and 20 min of incubation. The samples were heated at 90°C for 2 min and applied to a 6% polyacrylamide-urea gel. The gel was dried, and gels were scanned on a Typhoon Trioϩ variable imager (GE Healthcare).
In vitro affinity interaction assay. To examine RNAP affinity to HAtagged Spx variants in vitro, the anti-hemagglutinin (HA) affinity matrix was used for the affinity binding assay as described previously (19) . Briefly, 0.25 M His-tagged SAd-RNAP and 2.5 M Spx⌬CHA were incubated with or without 0.25 M A in 150 l of reaction buffer (RB; 10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 5 mM MgCl 2 ) at room temperature for 20 min, and the protein mixture then was applied to the anti-HA affinity column, followed by washing with washing buffer (0.05% Tween 20 in RB). The protein complex was eluted from the column with 100 mM triethylamine, pH 11.5, and neutralized with 1/10 volume of 1 M TrisHCl, pH 6.8. The composition of protein complex was analyzed on the SDS-polyacrylamide gel, followed by Coomassie blue G250 staining.
For individual RNAP subunit binding assays, equal concentrations of ␣, ␣CTD, and/or A proteins were incubated with 2.5 M Spx in RB for 20 min. The pulldown procedure detailed above then was conducted.
Quantification of band intensities was performed by using ImageJ software on multiple gel images, and the ratio of each RNAP subunit binding to the mutant Spx to that of wild-type Spx was calculated and is presented in histograms.
Promoter DNA-protein cross-linking. Cross-linking probes were synthesized as described previously (22), with some modifications. Briefly, biotinylated trxB promoter DNA fragment was generated by PCR using forward 5=-biotinyl-oligonucleotide oDYR06-02 and reverse oligonucleotide oDYR06-03 specifically amplifying trxB promoter DNA from Ϫ98 to ϩ22. This DNA fragment was purified using low-melting-point agarose gel extraction and then incubated with streptavidin-conjugated magnetic beads (Dynabeads M280 streptavidin; Invitrogen). Biotinylated trxB DNA bound to the beads was denatured with 0.1 M NaOH and 1 M NaCl, and streptavidin-bound single-stranded trxB promoter was collected by centrifugation and washed with 10 mM Tris-HCl, 1 mM EDTA (TE; pH 7.5) buffer containing 0.1% BSA. Oligonucleotides containing a single 3= phosphorothioate substitution at the desired nucleotide positions on the trxB promoter (see Table S2 in the supplemental material) were then annealed to the streptavidin-bound single-stranded DNA template and radiolabeled with 120 mCi [␣-
32 P]dATP (MP Biomedicals) using Klenow fragment (3=¡5= exonuclease) enzyme (New England BioLabs) at an adjacent position. After washing off excess free [␣-
32 P]dATP, the full-length extension was performed by adding Klenow fragment (3=¡5= exonuclease) and deoxynucleoside triphosphate (dNTP) mix. The extension reaction was stopped by washing off Klenow enzyme and free dNTP by centrifugation and resuspension in NEBuffer 2 (New England BioLabs). The radiolabeled DNA was released from the streptavidin beads by cleavage with HaeIII (New England BioLabs). The released, radiolabeled DNA was extracted with phenol-chloroform-isoamyl alcohol (PCI) solution and precipitated with ethanol. The promoter DNA was derivatized with 100 mM p-azidophenacylbromide (APB) in 100 mM triethylammonium bicarbonate buffer (pH 8.0) in the dark at room temperature overnight. The derivatized products were then PCI extracted, ethanol precipitated, and dissolved in distilled water.
For the cross-linking experiments, 0.25 M RNAP with 2.5 M Spx or Spx variants were incubated with radiolabeled probes (10,000 cpm) at 37°C for 30 min in the dark in buffer containing 20 mM Tris-HCl (pH 8.0), 50 mM KCl, 5 mM MgCl 2 , 0.1 mg/ml BSA, and 5% glycerol. Crosslinking was carried out by UV irradiation (UV Stratalinker 1800; Stratagene) for 10 s, and then samples were immediately transferred to ice. Samples were treated with 80 U DNase I at 37°C for 1 h, and the crosslinked products were resolved on an 18% SDS-PAGE gel. The dried gels were scanned on a Typhoon Trioϩ variable imager (GE Healthcare).
RESULTS
Mutational analysis identified residues near the redox switch and within the helix ␣4 that are important for trxB transcriptional activation. Optimal Spx-stimulated transcription requires the formation of a disulfide bond between C10 and C13 in Spx. The structures of the oxidized Spx and reduced C10S Spx in com-plex with RNAP ␣CTD have been resolved (20, 32, 44) . A significant conformational change was found between the oxidized and reduced forms of Spx (Fig. 1) , whereby the helix ␣4 in mutant C10S Spx was unfolded when the disulfide bond could not be formed. It is likely that the formation of a disulfide bond leads to the structural change in helix ␣4 of Spx and further enables Spx to activate transcription by facilitating target promoter or RNAP contact. To investigate whether the residues within helix ␣4 are necessary for the function of Spx and whether residues in the vicinity of the redox center conserved in ArsC are involved in transcriptional activation, single-amino-acid substitutions were introduced within the helix ␣4 region and near the redox disulfide center in the linker region separating the redox and central domains of the Spx protein to examine their effects on Spx activity. To prevent the degradation of Spx by ClpXP protease under nonstress conditions, we expressed the ClpXP-resistant forms (SpxDD) of the wild-type and mutant proteins from an IPTGinducible promoter and evaluated the effect of Spx amino acid substitutions on Spx-dependent trxB-lacZ transcription in vivo in the presence of IPTG. The relative activity of the mutant to the wild-type Spx product and production of each Spx protein, as observed by Western blot analysis, are shown in Fig. 2 . Previous mutational analyses showed that the residue C10 in the redox disulfide center and R60 and K62 residues in the helix ␣4 region are important for the transcriptional activation of trxB (21, 32) . The Spx(R60E) mutant markedly reduced transcriptional activation in vivo and in vitro, and the Spx(R60E)/␣CTD complex could not interact with DNA (32) . As shown in a previous study, Spx(C10A) and Spx(R60E) mutants significantly reduced the trxB transcription, and the K62E mutant was also moderately defective in transcription activation ( Fig. 2A) . This confirmed that the R60 residue plays an important role in the interaction between Spx/ RNAP and promoter DNA. The F64A mutant showed an effect similar to that of K62E. When F64 was replaced with tryptophan, another amino acid bearing an aromatic side chain, the activity of Spx was restored, which implied that the aromatic ring at this position in ␣4 was involved in forming a proper structure for Spx function. The other three mutants, Q65A, N68A, and N70A, in the helix ␣4 region showed no effect on transcription activation. We also investigated the effect of residues around the redox disulfide center required for trxB transcriptional activation. The Y5 residue in the N-terminal sheet ␤1 near the redox center was replaced with alanine, but the production of mutant protein was not detected by Western blot analysis (Fig. 2B) ; hence, the decreased transcriptional activity is due to low levels of Spx ( Fig. 2A) . However, the Y5F mutant protein is stable, and its activity is similar to that of wild-type Spx, indicating that an aromatic side chain is required at this position. The function of Y5 is structural apparently and is not directly involved in Spx-dependent transcriptional activation.
The R92 residue is conserved in arsenate reductase and is thought to heighten the C10 thiolate reactivity (45) . The side chain of R92, which is in the vicinity of C10 and the helix ␣4 region in Spx, turns away from the disulfide upon Spx oxidation (Fig. 1) . Next to R92 is another conserved arginine, R91, which in some Spx orthologs is replaced with a lysine. Both Spx mutations, R91A and R92A, reduced the trxB-lacZ expression up to 30 to 40% (Fig.  2) . However, the R91A R92A double mutant showed synergistic effects on the trxB transcription and almost abolished transcription (Fig. 3A) . This result implies that the two arginine residues play different roles in Spx-dependent transcription regulation. To determine whether the effect of these two arginine substitutions is specific to Spx transcription activation, the involvement of the two substitutions in the negative control was examined by measuring the expression of an srfA-lacZ construct. As reported previously, ComA-dependent transcriptional activation of srfA is repressed by Spx in vivo and in vitro (31) . The R92A mutant form of Spx produced in the presence of IPTG could still repress srfA transcription as well as the wild-type Spx, but the R91A mutant lost the ability to repress srfA transcription (Fig. 3B ). This result indicated that Spx R92A mutation affected transcription activation but was able to engage RNAP. In contrast, R91A mutant Spx is defective in RNAP interaction, since neither Spx-dependent positive nor negative control was fully operational. For the R92 residue, the crystal structure of Spx in the sulfate-free condition showed movement of the R92 residue when the disulfide formed, but a conformational change in the helix ␣4 region was not detected (Fig. 1, left) (44) . To examine whether the structure of the side chain of R92 is important for the transcriptional activation, the R92 residue was replaced with a glutamine residue, which has a similar side chain geometry but is uncharged. However, LacZ assay results showed that the Spx(R92Q) mutant also had 30% reduction of trxB transcription, which was similar to the defect conferred by the R92A mutation (see Fig. S1 in the supplemental material). To test if the positive charge of the Arg side chain is required for optimal activity, R92 was replaced with a lysine, but this did not restore the level of Spx activity in vivo to that of the wild-type parent protein (see Fig. S1 ). This suggests that the role of R92 is not to contribute a positive charge for the electrostatic interaction of Spx with DNA, which its interaction with a sulfate ion within the crystal structure was thought to imply (20, 44) .
The phenotype of the double mutants suggests a role of R92 in redox control of Spx. Several additional residue substitutions were introduced in the spx(R92A) mutant to create a series of double mutants, including Spx(C10A, R92A), Spx(R60E, R92A), and Spx(K62E, R92A), and trxB-lacZ activity was examined in these mutant strains. Western blot analysis indicated that mutant Spx proteins were within a 2-fold range of intracellular concentrations (Fig. 4B) . The results indicate that the C10A mutation is epistatic to R92A in the Spx(C10A, R92A)-expressing strain, as the same level of activity as that of the Spx(C10A) mutant was observed ( Fig. 4A and B) . In contrast, R60E or K62E, together with R92A, showed synergistic negative effects on trxB transcription, because Spx(R60E, R92A) nearly abolished trxB-lacZ expression (Fig. 4A) , and Spx(K62E, R92A) reduced transcription to the same extent as the Spx(C10A) mutant (Fig. 4B) . These results indicate that the R92A phenotype cannot be observed in the C10A background and is observed only if the C10-C13 disulfide bond is able to form. It suggests that the effect of the R92A residue on transcription is connected to disulfide formation and redox control of Spx. In contrast, combining the R92A mutation with R60E results in an additive effect, suggesting that the two residues perform separate functions that contribute to Spx-activated transcription.
Residue substitutions at R91 and R92 reduce Spx activity in vitro. To verify the effect of Spx(R91A) and Spx(R92A) mutant proteins in vitro, each protein, purified as shown in Materials and Methods, was applied to a transcription reaction with purified RNA polymerase and the supercoiled template (43) containing trxB promoter DNA. A time course transcription was performed (Fig. 5) , and the effect of Spx mutants was compared to that of wild-type Spx at each time point. The intensity of the transcript was quantified and normalized by using an internal control transcript encoded by plasmid-borne rna1. The effect of Spx mutants was presented as percent normalized trxB transcription relative to that observed in reaction mixtures containing wild-type Spx (Fig.  5, bottom) . Both R91A and R92A mutations conferred reduced transcription-stimulating activity, with levels of in vitro-generated transcripts below those synthesized by wild-type Spx/RNAP. Spx(R91A) mutant is defective in RNAP binding. To examine whether the R91 and R92 residue substitutions affect Spx-RNAP interaction, an epitope affinity chromatography system designed to capture Spx bound to RNAP was performed as described previously (19) . Briefly, epitope-tagged versions of the Spx mutants (Spx⌬CHA) were created in which the last 12 C-terminal residues were replaced with an HA (influenza hemagglutinin) tag. The Spx⌬CHA protein is functional in vivo (19) . The tagged Spx mutant proteins were produced and purified by using a chitin-bind- ing affinity chromatography system, followed by two more column purification steps. His-tagged A -depleted RNAP (SAd-RNAP) was purified from the sigA(L366A) B. subtilis strain as previously described (19) , and recombinant A protein was purified with a chitin-intein affinity column system (19) . The binding of SAd-RNAP or SAd-RNAP with A subunit (holo-RNAP) to Spx(R91A⌬CHA) and Spx(R92A⌬CHA) was examined by the anti-HA Affi-Gel pulldown reaction. After RNAP and HA-tagged Spx were incubated and applied to an anti-HA affinity column, protein complexes were eluted with high pH buffer and analyzed by SDS-PAGE ( Fig. 6A and C) . The association of each RNAP subunit of the complex with the mutant Spx was quantified and is presented as a ratio to the values derived from reaction mixtures containing wild-type Spx (Fig. 6B and D) . Both of the arginine substitutions significantly affected RNAP binding. Spx(R91A⌬CHA) exhibited severely reduced binding to SAd-RNAP ( Fig. 6A and B) , but the binding was improved in the presence of A subunit ( Fig. 6C and D) . Spx(R92A⌬CHA) showed higher affinity to SAd-RNAP than the R91A derivative, but this level was still lower than that of wild-type Spx. Addition of A subunit improved Spx(R92A⌬CHA)-RNAP interaction ( Fig. 6B  and D) .
To examine whether the mutants affect binding of individual RNAP subunits, the purified ␣ C-terminal domain (␣CTD) and A subunit were applied to the anti-HA Affi-Gel pulldown assay. First, the binding of ␣CTD and A subunit to the Spx⌬CHA mutant was tested. As expected, Spx did not interact with the A subunit; however, surprisingly, the ␣CTD showed little affinity for Spx⌬CHA (Fig. 7A) , although interaction was detected with a yeast two-hybrid system (31) and the crystal structure of the Spx/ ␣CTD complex was solved ( Fig. 1) (19, 20, 44) . This indicates that the interaction between Spx and ␣CTD is weak and could be disrupted under the conditions of our pulldown experiment. Hence, we purified intact ␣ subunit to examine whether ␣ subunit-Spx interaction requires the ␣ dimer. The purified ␣ subunit was confirmed as a dimer by gel filtration chromatography (data not shown). The result of the affinity interaction assay showed that Spx interacts with intact ␣ but not ␣CTD (Fig. 7B) . Evidence that intact ␣ subunit bears an Spx-binding surface was obtained by far-Western blotting using preincubation of gel-resolved and im-
FIG 4
Effect of Spx R92A mutant on the amino acid substitutions in the redox switch or in the helix ␣4 region on trxB-lacZ transcription. The IPTG-inducible alleles encoding Spx(R92A)DD with amino acid substitutions in either the redox switch (C10) or helix ␣4 region R60 (A) or K62 (B) were introduced into the amyE locus of the Spx null mutant strain bearing trxB-lacZ. The ␤-galactosidase assay was performed as described in the legend to Fig. 3 , and the highest activities of Spx mutants were taken and calculated as a ratio to that of SpxDD (as explained in the legend to Fig. 2 ). Spx levels in these strains were determined by Western blotting using anti-Spx antibody, and results are shown in the bottom panel.
FIG 5
In vitro transcription from the plasmid carrying the trxB promoter in the absence and presence of the wild-type Spx or the Spx(R91A) or Spx(R92A) mutant. The plasmid DNA containing the trxB promoter region (10 nM) was incubated with 10 nM reconstituted B. subtilis RNAP (SAd-RNAP, A ϭ 1:3) and 10 nM Spx, Spx(R91A), or Spx(R92A), and the reaction was performed in a time course manner. Band intensity of each trxB transcript was quantified and normalized to that of the RNA-1 transcript. The trxB transcription level activated by each Spx mutant was calculated and is presented as a percentage compared to that activated by wild-type Spx. mobilized RNAP proteins with Spx, followed by reaction with anti-Spx antiserum (data not shown). These experiments showed that only intact ␣ subunit, but not ␣CTD or A , could interact with Spx. This suggests that contact surfaces, apart from ␣CTD, are required for optimal ␣-Spx interaction.
To examine the effect of Spx mutant proteins on ␣/Spx interaction, the affinity of Spx⌬CHA and mutant derivatives for the ␣ subunit was examined with an anti-HA Affi-Gel interaction assay (19) . The Spx R60E and R92A mutants did not show a significant defect in ␣ binding (Fig. 8A, lanes 5 and 6, and B) , and the C10A mutant only slightly reduced affinity to the ␣ subunit (Fig. 8A,  lane 4, and B) . It has been known that the G52 residue constitutes part of the ␣CTD-Spx interaction interface (20, 21) , and as previous results showed, ␣ binding to the Spx(G52R)⌬CHA mutant was significantly reduced to 40% compared to that of Spx⌬CHA (Fig. 8A, lane 2, and B) . The Spx(R91A)⌬CHA protein, which is defective in binding to SAd-RNAP ( Fig. 6A and C) , showed a more severe effect on ␣ binding than the G52R mutant (Fig. 8A, lane 3,  and B) . The result suggests that the defective SAd-RNAP binding to the Spx(R91A) mutant was attributed to the weakened ␣-Spx interaction and indicates that the R91 residue is important for ␣ interaction, and it further suggests that Spx establishes multiple contacts with the ␣ subunit dimer.
We reasoned that R91 could be another contact point between Spx and the ␣ dimer, or that the R91A mutation alters indirectly the previously identified ␣-binding surface of Spx, defined by the G52R substitution. Previous studies showed that the G52R substitution resulted in a 75% reduction in Spx-RNAP interaction according to affinity interaction assay results (19) . The R91A G52R double mutant was constructed to determine if the phenotype resembled that of the G52R mutant, suggesting that R91 participates in supporting the structure of the ␣CTD-binding surface of Spx. The Spx(G52R, R91A) mutant protein was produced in B. subtilis in the stable DD form, and the effect of its expression was tested by measuring the activity of the trxB-lacZ fusion. Introduction of the R91A substitution into the Spx(G52R) mutant resulted in nearly complete elimination of activity (see Fig. S2 in the supplemental material). The affinity interaction assay using a version of Spx(G52R, R91A) that bears the C-terminal HA tag and using an anti-HA Affi-Gel column showed that interaction between R91 or G52R mutant protein and the ␣ dimer is eliminated when the two substitutions are combined in the Spx monomer (see Fig. S2 ). This result, along with the observation of weak interaction of the Spx monomer with ␣CTD and stable interaction with the ␣ dimer, suggests that the Spx protein has an additional ␣ contact surface, defined by the R91 residue, within the linker region separating the central and redox domains of the Spx protein.
Nucleotide-specific DNA-protein cross-linking shows that Spx interacts with the conserved AGCA motif and repositions A in the trxB promoter region. Thus far, there is no evidence showing that Spx directly interacts with DNA. Our previous work identified two potential cis elements required for Spx-activated trxB transcription at positions Ϫ44 and Ϫ33 (Fig. 9A, boxes) (22, 32) . A sequence in nfrA, trxA, and trxB promoter regions centered at Ϫ44 and bearing the sequence AGCA was found to be the location of mutations that reduced Spx-stimulated transcription. These findings were supported by the recently reported ChIP analysis (14) . The A/TGCA/T sequence upstream of the Ϫ35 core promoter element is conserved in promoters that interact with Spx/RNAP in vivo. The element resides in the DNase I-protected region when trxA or trxB promoter DNA is bound to Spx/RNAP (14, 21, 22) . These results suggest that the upstream Ϫ44 cis element is a site where Spx contacts Spx-activated promoter DNA when bound to RNAP.
The interaction of RNAP and Spx with the trxB promoter DNA was examined by nucleotide-specific protein-DNA cross-linking (22) . This was conducted by incubating RNAP and Spx with DNA fragments that were APB (p-azidophenacyl bromide) derivatized and radioactively labeled at specific nucleotide positions in the trxB promoter, followed by photo-cross-linking and DNase I treatment. Radiolabeled, cross-linked proteins were then identified by SDS-PAGE and phosphorimaging. Radiolabeled promoter DNA fragments that were modified with phosphothioate and APB were active as the templates for in vitro transcription reaction mixtures containing Spx/RNAP (data not shown). The binding of Spx/RNAP complex to the eight positions, Ϫ11, Ϫ21, Ϫ36, Ϫ40, Ϫ44, Ϫ46, Ϫ49, and Ϫ51 ( Fig. 9 ; also see Fig. S3 in the supplemental material), on the trxB promoter was examined. A previous report showed that in the presence of Spx, a strong A crosslinking signal using a probe labeled at position Ϫ11 was generated (22) , and no significant cross-linked Spx was detected at Ϫ11. Spx also caused elevated generation of a cross-linked product containing the large RNAP subunits and modified position Ϫ21 of the trxB promoter. This result was confirmed in the current study (see Fig. S3, lane 4) . Previously reported results also showed that Spx(C10A) and Spx(G52R) mutations failed to induce A contact with a Ϫ11 region cross-linker-modified probe (22) . The result suggests that oxidized Spx promotes A contact with the Ϫ10 region on the trxB promoter during transcription initiation. Among the eight positions tested, there were no significant changes in the interactions of each RNAP subunit to DNA at Ϫ46, Ϫ49, and Ϫ52 when Spx was present in the cross-linking reaction (see Fig. S3 ), although at position Ϫ46, stronger cross-linked A signal was detected (see Fig. S3, lanes 10 and 12) than at the other two positions.
In the absence of Spx and in a reaction mixture containing only RNAP incubated with DNA, significant cross-linking of ␤␤= with the Ϫ44 probe was detected (Fig. 9A, lane 3) , especially compared to the level of cross-linked product at Ϫ36 (lane 1). Strong A cross-linking to the Ϫ44 probe was also observed, which could be due to the Ϫ35-like element located in the Ϫ44 region of the trxB promoter (Fig. 9A, lane 3, and B) . In the presence of Spx, a strong band representing Spx cross-linked to position Ϫ44 was observed, and less cross-linked product was formed in reaction mixtures containing DNA modified at positions Ϫ40 and Ϫ36 (Fig. 9A,  lanes 4 to 6) . The Ϫ44 position is within the AGCA motif believed to serve as the Spx-specific cis-acting control element. In the presence of Spx, enhanced cross-linked A protein at position Ϫ36 was observed (Fig. 9A, compare lanes 4, 10, and 19 to lane 1) . This result indicates that Spx interaction with RNAP repositions the A subunit from the nonproductive position, Ϫ44 in the trxB promoter region, to Ϫ36, where A protein normally interacts when RNAP contacts the core promoter elements. Higher concentrations of RNAP (to 0.5 M) resulted in reduced cross-linking of Spx to position Ϫ44 and less binding of A to Ϫ36 (data not shown). Part of the reason for this result is the heightened competition for the Ϫ44 sequence on the part of A , where some A is observed to contact in the overlapping Ϫ35-like element.
The effect of Spx residue substitutions on DNA binding was also examined. The R60E mutant, which, when combined with the ␣CTD, showed defective binding to trxB DNA in previous electrophoretic mobility shift assays (EMSAs) (32) , showed significantly reduced binding at position Ϫ44 compared to that of wildtype Spx (Fig. 9A, lane 9) .
A cross-linking at this position was also reduced. This indicates that the Spx(R60E) mutant is still capable of interacting with RNAP, preventing A contact with DNA at Ϫ44, but fails to promote Spx/RNAP interaction with the trxB core promoter. The C10A mutant, conferring a defect in the redox center, almost abolished the binding ability of Spx to the DNA at Ϫ44 (Fig. 9A, lane 15) , and, as with the R60E mutant, the nonproductive A binding was reduced (Fig. 9A, lane 15 versus lane 3) . This implies that the C10A mutant still retains some affinity to RNAP, as shown in previous affinity interaction assays; however, since it fails to facilitate a conformational change in the helix ␣4 region under oxidizing conditions, the DNA-binding ability is affected (21, 32) , which prevents productive Spx/RNAP-promoter contact. This conclusion is supported by previous work showing reduced interaction of A with position Ϫ11 when the SpxC10A mutant protein is complexed with RNAP (22) . The residue substitutions G52R, R91A, and R92A all caused reductions in the level of contact between RNAP subunits and positions Ϫ36, Ϫ40, and Ϫ44 (Fig. 9A, lanes 15 to 18 and 22 to 27 ) compared to the pattern of RNAP cross-linking in reaction mixtures containing wild-type Spx. The two Spx mutants, G52R and R91A, which show defective binding to RNAP and ␣, also showed significant reductions in DNA cross-linking at Ϫ44 (Fig. 9A, lanes 18 and 24) . The R92A mutant cross-linked to position 44 and showed a slight defect in A binding to position Ϫ36 (Fig. 9A, lane 27 ), as the mutation had a modest, albeit reproducible, effect on transcriptional activation (Fig. 2 and 5 ).
The enhanced cross-linked A protein observed at positions Ϫ11 and Ϫ36 in the presence of Spx indicates that Spx, when bound to RNAP and contacting the Ϫ44 promoter element, redi- 
rects
A subunit to properly interact with Ϫ10 and Ϫ35 consensus elements on the trxB promoter as part of its mode of action during transcriptional activation. Figure 9B and C present a summary of the cross-linking data involving interaction of RNAP subunits with the trxB promoter in the absence and presence of Spx.
DISCUSSION
Previous studies indicated that the region of Spx that includes the small ␣4 helix and residues within the linker region separating the redox and central domains (Fig. 1) undergoes conformational changes upon transition from reduced/thiol to oxidized/disulfide states (32) . This transition affects interaction of Spx-␣CTD with target promoter DNA. Previous work also showed that a single monomer of Spx engages the RNAP holoenzyme, suggesting that Spx targets not only the ␣CTD but also another subunit/domain within the holoenzyme complex (19) . Evidence presented here shows that three arginine residues at the end of ␣4 and within the Spx linker region (R60, R91, and R92) exert effects on (i) Spx-RNAP interaction, (ii) contact of Spx with a conserved cis-acting element in the target promoter of trxB, and/or (iii) Spx-dependent positioning of the RNAP A subunit with the core promoter element trxB.
Spx interaction with RNAP. One of the questions regarding Spx function is how it interacts with RNAP. In an earlier work, Spx was shown to have higher affinity for RNAP holoenzyme than for RNAP depleted of A subunit (19) . However, several studies have not detected contact between Spx and A (current study and K. J. Newberry and P. Z. R. G. Brennan, unpublished data). Affinity interaction assays and far-Western blot analysis using Spx and anti-Spx antibody, along with gel-resolved and filter-immobilized RNAP subunits (data not shown), showed interaction of Spx only with the ␣ subunit and not the A subunit or the ␣CTD. The data presented above indicate that Spx targets the ␣ dimer and is shown to have higher affinity for intact ␣ subunit than the ␣CTD, despite the fact that an Spx/␣CTD complex has been obtained by coexpression in E. coli (44) . Mutational analysis suggests that in addition to the ␣CTD-binding interface in the central domain of Spx, there is also an ␣ subunit contact point in the linker defined by the R91 residue. The phenotype of R91 might relate to the observation that only one Spx monomer is required to productively interact with RNAP (19) . The two ␣ contact points defined by G52R and R91A might mediate formation of a bridge between the two ␣ monomers, thereby occupying a position in the ␣ dimer that can only accommodate a single Spx monomer. It is not clear why Spx prefers contact with RNAP holoenzyme over that with SAd-RNAP, but the presence of A in the holoenzyme might promote a conformation of the ␣ dimer that maximizes Spx contact. It is also possible that Spx contacts A only when the two proteins are incorporated into the holoenyzme complex.
Redox control of Spx. It is known that Spx can undergo oxidation to the disulfide form, a reaction that heightens Spx activity in terms of promoting RNAP interaction with the regulatory regions of some Spx-activated genes (21) . The mechanism behind this process is currently unclear, but evidence provided here suggests that R92 participates in thiol/disulfide redox control. The C10A mutation eliminates the transcription-stimulating activity of Spx in vitro, while SpxDD(C10A) shows an 80% reduction in activity in vivo compared to SpxDD. Introduction of a second substitution at R92 does not change the level of mutant Spx activity in vivo, indicating that C10A is epistatic to R92A, and the mutant phenotype of R92A is observed only when a disulfide can be generated. Such epistasis experiments using multiple residue substitutions has been applied to uncover protein-protein contact surfaces on SoxS and its binding partner, 70 of E. coli RNAP (46, 47) . It is not clear how the R92 side chain transduces a redox signal from the disulfide center to the target-interacting surfaces of Spx and ultimately to RNAP. The reduced Spx structure of Lamour et al. shows a subtle rotation of the R92 side chain compared to the structure of oxidized Spx determined by Newberry et al. (20, 44) . On the other hand, the R92 side chain in the structure of the SpxC10S mutant veers away from the C10 position and toward ␣4 helix. The possibility of other residues functioning in the transmission of redox control is currently being investigated.
Spx/RNAP interaction with promoter DNA. The presumed cis-acting element within the regulatory region of Spx-activated genes is located in a sequence around position Ϫ44 with respect to the transcriptional start site; it is usually AGCA and is followed by an AT-rich sequence. Construction of hybrid promoters, site-directed mutagenesis, and alignment of sequences that interact with Spx/RNAP in vivo (14, 22, 32) all indicate that the conserved upstream A/TGCA/T sequence centered around position Ϫ44 is required for Spx/RNAP interaction with promoter DNA. This is supported by nucleotide-specific protein-DNA cross-linking, in which wild-type Spx, when complexed with RNAP, is shown to contact the derivatized Ϫ44 nucleotide position (Fig. 9 ). This is accompanied by strong cross-linking signals caused by contact between A and the Ϫ10 and Ϫ35 regions of the trxB promoter. Indications from EMSA that Spx, in combination with the ␣CTD, could generate a DNA-binding complex were reported previously (32) . As previously reported and presented here, Spx(R60E) can form a complex with ␣CTD and RNAP (19, 32) but does not promote transcriptional activation, most likely due to the failure to contact target DNA, which is necessary to induce A binding to core promoter elements (Fig. 9) . Codon substitutions (G52R and R91A) in spx that confer defects in RNAP binding also compromised cis-element contact, as shown in the cross-linking data.
In the trxB promoter region, there is a Ϫ35-like element that overlaps with the AGCA sequence, and cross-linking indicates that this element contacts the A subunit of holoenzyme. In the absence of Spx, the Ϫ36 position is poorly contacted by A , but contact between A and Ϫ36 is evident in the presence of Spx (Fig.  9) . Thus, it seems that Spx repositions A when it is bound to RNAP. The data also suggest that some Spx-dependent remodeling of holoenzyme takes place prior to DNA interaction. Mutant Spx proteins [Spx(R60E), for example] also reduce interaction of A with position Ϫ44 without significant Spx contact with the Ϫ44 cis element. While this suggests that remodeling of RNAP by Spx occurs at the pre-DNA-binding stage, A -promoter interaction involves Spx contact with the Ϫ44 element as part of the Spx/RNAP/promoter complex.
Data presented here and reported previously (32) indicate that R60 is important for contact with the Ϫ44 element. Amino acid residue substitutions affecting RNAP binding (G52R and R91A) cause a reduction in contact between Spx at position Ϫ44 and A at Ϫ36 (Fig. 9) . The R92A mutation affects interaction of Spx at Ϫ44 and A at Ϫ36 as well, which could account for its intermediate negative effect on in vivo and in vitro Spx activity. There is little, if any, specific contact between Spx/RNAP complex and DNA upstream at positions Ϫ49 and Ϫ52 (see Fig. S3 in the supplemental material).
A model of Spx/RNAP-trxB promoter contact is shown in Fig.  10 . This model does not explicitly include the possible involvement of multiple ␣ contact surfaces on Spx. The interaction of ␣ subunits with DNA ( Fig. 10) also is speculative at this point, but we are of the opinion that one of the ␣CTDs contacts the AT-rich region between the Ϫ44 element and the Ϫ35 region.
The current study provides evidence for multiple RNAP-binding surfaces on Spx, the resulting interaction of which causes remodeling of RNAP so that A contacts the Ϫ35 and Ϫ10 core promoter elements. This is further facilitated by interaction of RNAP-bound Spx protein with the Ϫ44 element that is conserved among the Spx-activated genes. The results reported here also suggest that redox control is transmitted in part through changes in positioning of the R92 side chain but will likely involve other conformational changes in the important linker region separating the redox and central domains of Spx. 
